• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉-静脉体外二氧化碳清除术治疗重度呼吸性酸中毒:病理生理及技术考量

Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations.

作者信息

Karagiannidis Christian, Kampe Kristin Aufm, Sipmann Fernando Suarez, Larsson Anders, Hedenstierna Goran, Windisch Wolfram, Mueller Thomas

出版信息

Crit Care. 2014 Jun 17;18(3):R124. doi: 10.1186/cc13928.

DOI:10.1186/cc13928
PMID:24942014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4095596/
Abstract

INTRODUCTION

While non-invasive ventilation aimed at avoiding intubation has become the modality of choice to treat mild to moderate acute respiratory acidosis, many severely acidotic patients (pH <7.20) still need intubation. Extracorporeal veno-venous CO2 removal (ECCO2R) could prove to be an alternative. The present animal study tested in a systematic fashion technical requirements for successful ECCO2R in terms of cannula size, blood and sweep gas flow.

METHODS

ECCO2R with a 0.98 m(2) surface oxygenator was performed in six acidotic (pH <7.20) pigs using either a 14.5 French (Fr) or a 19Fr catheter, with sweep gas flow rates of 8 and 16 L/minute, respectively. During each experiment the blood flow was incrementally increased to a maximum of 400 mL/minute (14.5Fr catheter) and 1000 mL/minute (19Fr catheter).

RESULTS

Amelioration of severe respiratory acidosis was only feasible when blood flow rates of 750 to 1000 mL/minute (19Fr catheter) were used. Maximal CO2-elimination was 146.1 ± 22.6 mL/minute, while pH increased from 7.13 ± 0.08 to 7.41 ± 0.07 (blood flow of 1000 mL/minute; sweep gas flow 16 L/minute). Accordingly, a sweep gas flow of 8 L/minute resulted in a maximal CO2-elimination rate of 138.0 ± 16.9 mL/minute. The 14.5Fr catheter allowed a maximum CO2 elimination rate of 77.9 mL/minute, which did not result in the normalization of pH.

CONCLUSIONS

Veno-venous ECCO2R may serve as a treatment option for severe respiratory acidosis. In this porcine model, ECCO2R was most effective when using blood flow rates ranging between 750 and 1000 mL/minute, while an increase in sweep gas flow from 8 to 16 L/minute had less impact on ECCO2R in this setting.

摘要

引言

虽然旨在避免插管的无创通气已成为治疗轻至中度急性呼吸性酸中毒的首选方式,但许多严重酸中毒患者(pH<7.20)仍需要插管。体外静脉-静脉二氧化碳清除(ECCO2R)可能是一种替代方法。本动物研究系统地测试了在插管尺寸、血液和吹扫气体流量方面成功进行ECCO2R的技术要求。

方法

使用0.98平方米表面的氧合器对6只酸中毒(pH<7.20)猪进行ECCO2R,分别使用14.5法国(Fr)或19Fr导管,吹扫气体流速分别为8和16升/分钟。在每个实验过程中,血流逐渐增加至最大400毫升/分钟(14.5Fr导管)和1000毫升/分钟(19Fr导管)。

结果

只有当使用750至1000毫升/分钟的血流速度(19Fr导管)时,严重呼吸性酸中毒的改善才可行。最大二氧化碳清除量为146.1±22.6毫升/分钟,而pH值从7.13±0.08升至7.41±0.07(血流速度1000毫升/分钟;吹扫气体流速16升/分钟)。相应地,8升/分钟的吹扫气体流速导致最大二氧化碳清除率为138.0±16.9毫升/分钟。14.5Fr导管的最大二氧化碳清除率为77.9毫升/分钟,这并未导致pH值正常化。

结论

静脉-静脉ECCO2R可作为严重呼吸性酸中毒的一种治疗选择。在这个猪模型中,当血流速度在750至1000毫升/分钟之间时,ECCO2R最有效,而在这种情况下,吹扫气体流速从8升/分钟增加到16升/分钟对ECCO2R的影响较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/8aa92be7a5a4/cc13928-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/d14414d4f161/cc13928-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/ae16cc89fad0/cc13928-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/64ce7dd85e8b/cc13928-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/bf6fd9e3c502/cc13928-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/7b75f4bbf100/cc13928-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/8aa92be7a5a4/cc13928-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/d14414d4f161/cc13928-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/ae16cc89fad0/cc13928-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/64ce7dd85e8b/cc13928-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/bf6fd9e3c502/cc13928-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/7b75f4bbf100/cc13928-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aa8/4095596/8aa92be7a5a4/cc13928-6.jpg

相似文献

1
Veno-venous extracorporeal CO2 removal for the treatment of severe respiratory acidosis: pathophysiological and technical considerations.静脉-静脉体外二氧化碳清除术治疗重度呼吸性酸中毒:病理生理及技术考量
Crit Care. 2014 Jun 17;18(3):R124. doi: 10.1186/cc13928.
2
Impact of membrane lung surface area and blood flow on extracorporeal CO removal during severe respiratory acidosis.严重呼吸性酸中毒期间膜肺表面积和血流量对体外二氧化碳清除的影响。
Intensive Care Med Exp. 2017 Dec;5(1):34. doi: 10.1186/s40635-017-0147-0. Epub 2017 Aug 1.
3
Impact of sweep gas flow on extracorporeal CO removal (ECCOR).吹扫气流对体外二氧化碳清除(ECCOR)的影响。
Intensive Care Med Exp. 2019 Mar 25;7(1):17. doi: 10.1186/s40635-019-0244-3.
4
Quantification of Carbon Dioxide Removal at Low Sweep Gas and Blood Flows.低吹扫气流量和低血流时二氧化碳清除的定量分析。
J Extra Corpor Technol. 2017 Dec;49(4):257-261.
5
Evaluation of CO removal rate of ECCOR for a renal replacement therapy platform in an experimental setting.评估 ECCOR 在实验环境下作为肾脏替代治疗平台的 CO 去除率。
Artif Organs. 2024 Jun;48(6):586-594. doi: 10.1111/aor.14718. Epub 2024 Feb 2.
6
Feasibility and safety of low-flow extracorporeal CO removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS.应用肾脏替代平台管理低流量体外 CO 去除对轻中度 ARDS 患者实施肺保护性通气的可行性和安全性。
Crit Care. 2018 May 10;22(1):122. doi: 10.1186/s13054-018-2038-5.
7
The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study.体外二氧化碳去除术避免 COPD 患者因急性高碳酸血症呼吸衰竭对无创通气无反应而插管的可行性和安全性(ECLAIR 研究):多中心病例对照研究。
Intensive Care Med. 2016 Sep;42(9):1437-44. doi: 10.1007/s00134-016-4452-y. Epub 2016 Jul 25.
8
The Homburg Lung: Efficacy and Safety of a Minimal-Invasive Pump-Driven Device for Veno-Venous Extracorporeal Carbon Dioxide Removal.洪堡肺:一种用于静脉-静脉体外二氧化碳清除的微创泵驱动装置的疗效与安全性
ASAIO J. 2017 Sep/Oct;63(5):659-665. doi: 10.1097/MAT.0000000000000522.
9
In vivo carbon dioxide clearance of a low-flow extracorporeal carbon dioxide removal circuit in patients with acute exacerbations of chronic obstructive pulmonary disease.在慢性阻塞性肺疾病急性加重患者中,低流量体外二氧化碳清除回路的二氧化碳清除率。
Perfusion. 2020 Jul;35(5):436-441. doi: 10.1177/0267659119896531. Epub 2020 Jan 11.
10
Respiratory Electrodialysis. A Novel, Highly Efficient Extracorporeal CO2 Removal Technique.呼吸电渗析。一种新型、高效的体外 CO2 去除技术。
Am J Respir Crit Care Med. 2015 Sep 15;192(6):719-26. doi: 10.1164/rccm.201502-0289OC.

引用本文的文献

1
Feasibility and safety of ultra-low volume ventilation (≤ 3 ml/kg) combined with extra corporeal carbon dioxide removal (ECCOR) in acute respiratory failure patients.超低容量通气(≤3毫升/千克)联合体外二氧化碳清除(ECCOR)用于急性呼吸衰竭患者的可行性和安全性。
Crit Care. 2024 Dec 27;28(1):433. doi: 10.1186/s13054-024-05168-8.
2
Safety and Effectiveness of Carbon Dioxide Removal CO2RESET Device in Critically Ill Patients.二氧化碳清除CO2RESET装置在危重症患者中的安全性和有效性
Membranes (Basel). 2023 Jul 24;13(7):686. doi: 10.3390/membranes13070686.
3
Highlights from the Respiratory Failure and Mechanical Ventilation 2022 Conference.

本文引用的文献

1
Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease.体外二氧化碳去除在慢性阻塞性肺疾病加重期促进拔管和活动的初步研究。
Ann Am Thorac Soc. 2013 Aug;10(4):307-14. doi: 10.1513/AnnalsATS.201301-021OC.
2
A novel extracorporeal CO(2) removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD.一种新型的体外 CO2 去除系统:在 COPD 患者伴有高碳酸血症性呼吸衰竭中的初步研究结果。
Chest. 2013 Mar;143(3):678-686. doi: 10.1378/chest.12-0228.
3
Determinants of oxygen and carbon dioxide transfer during extracorporeal membrane oxygenation in an experimental model of multiple organ dysfunction syndrome.
2022年呼吸衰竭与机械通气会议亮点
ERJ Open Res. 2023 Mar 20;9(2). doi: 10.1183/23120541.00467-2022. eCollection 2023 Mar.
4
A randomised controlled trial of non-invasive ventilation compared with extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease.一项针对慢性阻塞性肺疾病急性高碳酸血症加重期患者,比较无创通气与体外二氧化碳清除的随机对照试验。
Ann Intensive Care. 2022 Apr 21;12(1):36. doi: 10.1186/s13613-022-01006-8.
5
Alkaline Liquid Ventilation of the Membrane Lung for Extracorporeal Carbon Dioxide Removal (ECCOR): In Vitro Study.用于体外二氧化碳清除(ECCOR)的膜肺碱性液体通气:体外研究
Membranes (Basel). 2021 Jun 22;11(7):464. doi: 10.3390/membranes11070464.
6
Extracorporeal Gas Exchange for Acute Respiratory Distress Syndrome: Open Questions, Controversies and Future Directions.用于急性呼吸窘迫综合征的体外气体交换:未解决的问题、争议与未来方向
Membranes (Basel). 2021 Feb 28;11(3):172. doi: 10.3390/membranes11030172.
7
Physiological effects of adding ECCOR to invasive mechanical ventilation for COPD exacerbations.在慢性阻塞性肺疾病(COPD)急性加重期有创机械通气中添加ECCOR的生理效应。
Ann Intensive Care. 2020 Sep 29;10(1):126. doi: 10.1186/s13613-020-00743-y.
8
Low-flow assessment of current ECMO/ECCOR rotary blood pumps and the potential effect on hemocompatibility.当前 ECMO/ECCOR 旋转血泵的低流量评估及其对血液相容性的潜在影响。
Crit Care. 2019 Nov 6;23(1):348. doi: 10.1186/s13054-019-2622-3.
9
SUPERNOVA: will its energy trigger the formation of a new therapeutic star?超新星:其能量会引发一颗新的治疗之星的形成吗?
Intensive Care Med. 2019 Jul;45(7):1032-1034. doi: 10.1007/s00134-019-05641-x. Epub 2019 May 20.
10
[Current techniques for extracorporeal decarboxylation].[当前的体外脱羧技术]
Med Klin Intensivmed Notfmed. 2019 Nov;114(8):733-740. doi: 10.1007/s00063-019-0567-6. Epub 2019 Apr 24.
体外膜肺氧合在多器官功能障碍综合征实验模型中氧和二氧化碳传递的决定因素。
PLoS One. 2013;8(1):e54954. doi: 10.1371/journal.pone.0054954. Epub 2013 Jan 29.
4
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study.低潮气量策略(≈3 ml/kg)联合体外 CO2 清除与严重 ARDS 中的“常规”保护性通气(6 ml/kg):前瞻性随机 Xtravent 研究。
Intensive Care Med. 2013 May;39(5):847-56. doi: 10.1007/s00134-012-2787-6. Epub 2013 Jan 10.
5
Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults.成人呼吸衰竭行静脉-静脉体外膜肺氧合时的血氧合和脱羧作用决定因素。
Intensive Care Med. 2013 May;39(5):838-46. doi: 10.1007/s00134-012-2785-8. Epub 2013 Jan 5.
6
Respiratory dialysis with an active-mixing extracorporeal carbon dioxide removal system in a chronic sheep study.主动混合式体外二氧化碳清除系统在慢性绵羊研究中的呼吸透析。
Intensive Care Med. 2012 Oct;38(10):1705-11. doi: 10.1007/s00134-012-2651-8. Epub 2012 Aug 25.
7
Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation.体外二氧化碳去除避免无创通气失败患者的有创机械通气。
Intensive Care Med. 2012 Oct;38(10):1632-9. doi: 10.1007/s00134-012-2649-2. Epub 2012 Jul 27.
8
Quantification of recirculation as an adjuvant to transthoracic echocardiography for optimization of dual-lumen extracorporeal life support.量化再循环作为经胸超声心动图辅助优化双腔体外生命支持的方法。
Intensive Care Med. 2012 May;38(5):906-9. doi: 10.1007/s00134-012-2534-z. Epub 2012 Mar 29.
9
Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008.美国 1998-2008 年无创通气治疗慢性阻塞性肺疾病急性加重的结局。
Am J Respir Crit Care Med. 2012 Jan 15;185(2):152-9. doi: 10.1164/rccm.201106-1094OC. Epub 2011 Oct 20.
10
Protective and ultra-protective ventilation: using pumpless interventional lung assist (iLA).保护性和超保护性通气:使用无泵介入性肺辅助(iLA)。
Minerva Anestesiol. 2011 May;77(5):537-44.